Very Early Onset of Inflammatory Bowel Disease in a Patient With Long-Segment Hirschsprung's Disease

Sharon Wolfson1, Kristin Whitfield Van Buren1,2

  • 1Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.

Insights

Hirschsprung's disease (HSCR), a congenital defect impacting the enteric nervous system, is linked to a higher prevalence of inflammatory bowel disease. This case study details a patient with HSCR who developed early-onset intestinal inflammation, suggesting a connection between neuroenteric issues and immune dysregulation.

Area of Science:

  • Gastroenterology
  • Developmental Biology
  • Immunology

Background:

  • Hirschsprung's disease (HSCR) is a congenital disorder characterized by the absence of ganglion cells in the distal bowel, leading to functional obstruction.
  • Patients with HSCR exhibit an increased incidence of inflammatory bowel disease (IBD), suggesting a potential shared pathophysiology.
  • The enteric nervous system's role in immune regulation is increasingly recognized, hinting at mechanisms linking HSCR and intestinal inflammation.

Observation:

  • A 12-month-old patient with long-segment Hirschsprung's disease presented with diffuse intestinal inflammation.
  • The clinical presentation was highly suggestive of very early onset inflammatory bowel disease (VEO-IBD).
  • This case highlights a severe manifestation of intestinal inflammation in a patient with a known congenital enteric nervous system defect.

Findings:

  • The patient's VEO-IBD developed subsequent to the diagnosis of HSCR.
  • Underlying neuroenteric abnormalities in HSCR may contribute to immune and inflammatory dysregulation in the gut.
  • This case provides a clinical example of the complex interplay between congenital gut defects and immune responses.

Implications:

  • Understanding the link between HSCR and IBD may lead to improved diagnostic and therapeutic strategies for affected children.
  • Further research into the neuro-immune axis in HSCR could reveal novel targets for managing intestinal inflammation.
  • This case underscores the importance of considering IBD in infants with HSCR presenting with gastrointestinal symptoms.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
834
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
696
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
765
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
359
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
558
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
662